Indoco Remedies Promoters Acquire Shares via Open Market
Indoco Remedies Ltd 路 Acquisition/ Disposal of Shares 路 04 Nov 2026, 8:20 pm
Indoco Remedies Promoters Acquire Shares via Open Market Promoter group members Aditi M. Panandikar and Madhura Suresh Kare acquired a combined 5,996 equity shares (0.006% stake) of Indoco Remedies Limited through open market purchases on 3rd Nov'26. Individually, Aditi Panandikar bought 3,000 shares (increasing holding from 3.177% to 3.180%), while Madhura Kare acquired 2,996 shares (increasing holding from 2.703% to 2.706%). Following this transaction, their collective shareholding in the company increased from 54,28,545 shares (5.880%) to 54,34,541 shares (5.887%) out of a total equity base of 9,23,18,455 shares.
Original exchange filing (PDF)
More announcements from Indoco Remedies Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare 路 09 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare 路 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 03 Nov 2026
- Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-09-2026 路 29 Oct 2026
- Audio recording of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026 路 27 Oct 2026
- Indoco''s Clinical Research Orgainsation - AnaCipher receives approval from ANVISA Brazil for its clinical and bioanalytical facilities 路 27 Oct 2026
